Lombard Medical

Executive Summary

Lombard Medical is a private medical device company headquartered in Oxford, UK, dedicated to innovative solutions for vascular diseases. Its lead product, the Altura endovascular stent graft system, is designed for minimally invasive treatment of abdominal aortic aneurysms (AAA). Featuring a unique dual-trigger delivery system, Altura offers simplified deployment and accurate placement, addressing key limitations of existing devices. The company has secured CE marking and generated initial commercial traction in select European markets, but remains in a growth phase, focusing on expanding clinical evidence and regulatory coverage. Lombard faces intense competition from established players like Medtronic, Cook Medical, and Gore, and its private status limits financial transparency. However, the differentiated technology and a large addressable AAA repair market present an attractive opportunity for strategic partnerships or acquisition. Key to success will be achieving broader regulatory approvals and demonstrating long-term clinical outcomes. Conviction is moderate given the competitive landscape and early commercial stage, but the potential for disruptive innovation in a sizable market supports a measured outlook.

Upcoming Catalysts (preview)

• Q1 2027FDA IDE Approval for US Pivotal Trial40% success
• Q3 202612-Month Clinical Data from European Post-Market Study70% success
• Q4 2026Strategic Partnership for Asian Distribution50% success